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Abstract 
Background: Patient reported outcome measures (PROMs) can evaluate the quality of health in 
patients with established renal failure.  There is limited experience of their use within national renal 
registries.   
Aim: To describe the Scottish Renal Registry’s (SRR) experience of collecting PROMS in the 
haemodialysis population and correlate PROMS to demographic and clinical parameters. 
Design:  Retrospective observational cross-sectional study.  
Methods: Haemodialysis patients in Scotland were invited to complete the KDQOL™-36 
questionnaire on the day of the annual SRR census in 2015 and 2016.  Questionnaires were linked to 
census demographic and clinical variables. 
Results: In 2016 738 questionnaires were linked to census data (39% of prevalent haemodialysis 
population).  Response rates differed with age (≥ 65 years 42%, < 65 years 36%) [χ2 p=0.006]; 
duration of renal replacement therapy (<1 year 46%, ≥1 < 5 years 38%, ≥ 5 years 33%) [χ2 p=0.002] 
and social class (Scottish Index of Multiple Deprivation (SIMD) Class 1 32%, Class 2 41%, Class 3 40%, 
Class 4 48%, Class 5 40%) [χ2 p<0.001].  There were significant differences in PROMs with age, SIMD 
quintile and primary renal diagnosis.  Achieving a urea reduction ratio of >65% and dialysing through 
arteriovenous access were associated with significantly higher PROMs.  PROMs were not affected by 
haemoglobin or phosphate concentration.   
Conclusions: Routine collection of PROMs is feasible and can identify potentially under-recognised 
and treatable determinants to quality of life.  The association between attaining recommended 
standards of care and improved PROMs is striking. Individual and population-wide strategies are 
required to improve PROMs. 
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Introduction 
Established Renal Failure (ERF) is the final stage in the progression of chronic kidney disease (CKD).  
The prevalence of ERF treated with renal replacement therapy (RRT) is low (0.1% of the Scottish 
population in 2015).1  However ERF confers excess morbidity and mortality compared with the 
general population, making it an important condition for patients and the healthcare service.  Both 
CKD and the treatments given for it can impact upon patients’ health-related quality of life 
(HRQOL).2 HRQOL deteriorates with progression of CKD, and is substantially reduced by the time 
patients reach ERF.3 
Clinicians have traditionally focussed on laboratory metrics to assess the success of treatment of 
ERF.  This can however lead to important problems going unrecognised, such as pain and fatigue, 
which have a major impact on HRQOL.4 Patient self-assessments should be included with laboratory 
metrics when assessing treatment outcomes. 
HRQOL can be assessed through self-completed Patient Reported Outcome Measure (PROM) 
questionnaires.5  The routine collection of PROMs in ERF is uncommon: in 2014 2 out of 23 European 
renal registries had experience in collecting them, and there was no consensus on the optimal tool 
for doing so.  Guidance on setting up and maintaining a PROMs programme was subsequently 
published, recommending the KDQOL™-36 questionnaire for data collection.6  The use of PROMs to 
increase CKD patient participation has also been highlighted in the UK Renal Registry 2017-2019 
strategy.7 
We describe the Scottish Renal Registry’s (SRR) experience of routinely collecting PROMs in 
haemodialysis patients over 2 consecutive years.  Our aims were to evaluate the practicality of a 
national renal registry collecting PROMs and assess whether there was correlation between results 
and routinely collected demographic and clinical parameters.  By doing so we hope to gain a greater 
understanding of our patients concerns, and improve the quality of care provided.    
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Methods 
Patients and Methods 
This is a retrospective cross-sectional observational study performed by the SRR.  The SRR is 
registered with the information commissioner under the terms of the data protection act via 
National Service Scotland (registration number Z5801192).  An initial pilot study was performed in 
May 2015, and a full survey in May 2016.   
Within Scotland there are 9 ‘parent’ renal units and 25 ‘satellite’ haemodialysis units.  In May 2016 
1878 patients were receiving hospital haemodialysis.    
Dialysis units invited their haemodialysis patients to complete the KDQOL™-36 questionnaire in the 
same week as collection of SRR annual census data.  Awareness of the process was raised via the SRR 
steering group member (a consultant nephrologist) from each renal unit.   
Questionnaires were distributed by local dialysis nurses.  Patients were asked to complete the 
questionnaire at home to minimise potential bias from completion whilst on dialysis or with dialysis 
staff present.  If patients required assistance or translation they were encouraged to ask a friend or 
relative to help.  With verbal consent, questionnaires were marked with their community health 
index (CHI) number to allow linkage with census data collected the same week. 
KDQOL™-36   
The KDQOL™-36 is a validated self-administered questionnaire.  It contains 36 questions separated 
into 5 components: 2 generic (physical functioning and mental functioning) and 3 disease-specific 
(symptoms/problems, effects of kidney disease on daily life, burden of kidney disease) which cover 
the different dimensions of HRQOL.8    
The generic components are contained in the Short Form which has 12 questions (SF-12) that cover 
physical and mental functioning.  The disease-specific component is derived from the KDQOL-
SF™v1.3, and contains 24 questions.  Disease-specific component scores range from 0 (lowest health 
rating) to 100 (highest health rating).  Clinically significant differences within these composite scores 
are in the region of 3-5 points.9   
Statistical Analysis 
Patient identifiable responses from the 2016 survey had their data linked to core SRR data and 
census derived variables.  Our analyst is trained in Information Governance and Security.  Data was 
analysed within the SRR therefore clinicians were not able to identify individual responses, 
maintaining confidentiality.   
Demographic variables comprised age, gender, time on renal replacement therapy (RRT), Scottish 
Index of Multiple deprivation (SIMD) quintile, primary renal diagnosis group (PRD) 
(glomerulonephritis, interstitial, multisystem, diabetes, unknown/missing) and whether dialysis was 
in a parent or satellite unit.  Clinical variables comprised haemoglobin concentration, urea reduction 
ratio (URR), adjusted calcium, phosphate, vascular access type, use of the buttonhole technique 
(whereby blunt needles are inserted via a tunnelled tract) and whether haemodialysis (HD) or 
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haemodiafiltration (HDF; combining convective and diffusive clearance) was used.  Response rate 
and scores from each of the 5 components of the KDQOL™-36 were compared with each of the 
above variables using chi-square analysis of contingency tables of the underlying frequencies and 
one-way ANOVA respectively.   Interactive and additive general linear models were performed to 
identify associations between the variables.  Correction for multiple comparisons was not applied 
partly due to the response rate; we have employed a p value of <0.05.  This should be borne in mind 
when interpreting results.10 
Pilot Study Survey 
A survey was sent to dialysis unit charge nurses following the 2015 pilot.  Questions were:  
1. Were you aware of our attempt to collect PROMs? 
2. If you were aware did your unit participate?  
 a) If yes – what barriers did you encounter?  Do you have suggestions to improve 
recruitment? 
 b) If no - why not? 
3. If your unit participated - would you be willing to again? 
Active on Transplant List 
SRR data regarding activation on the national kidney transplant waiting list on 31st December 2015 
were retrieved for patients starting RRT between 1st January 2010 and 31st December 2014 who had 
participated in PROMs and were identifiable.   
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Results 
Pilot Study 2015 
555 questionnaires were returned from 20 out of 35 dialysis units, comprising 29% of the hospital 
haemodialysis population.  270 responses had a CHI number (15% prevalent haemodialysis 
population).   
Dialysis Unit Survey 
Survey responses were obtained from 26 of the 35 units (74%).  Of those who replied, 18 (69%) were 
aware of the plan to survey PROMs and 15 of these participated (83%).  Units who were aware but 
did not participate indicated that short notice prevented their involvement.  Other barriers included 
patients preferring not to be identified and time pressures.  Some staff felt patients may be less 
honest if they thought their response would be read by people who knew them.  Suggested 
solutions were a post box for questionnaire return and an independent person to assist with 
administration.  All units were willing to participate again. 
Following feedback, efforts to raise awareness of PROMs were made through the SRR steering group 
and dialysis charge nurses.  The questionnaire was adjusted to give a clear place to record CHI 
number and the covering instruction letter was updated. 
2016 Study: Response Rate 
896 questionnaires were returned (48% prevalent hospital haemodialysis population).  738 
questionnaires had an identifiable CHI number and were linked to census data (39% of prevalent 
population).  The median age of respondents was 66 years (IQR 56,74 years) and median time on 
RRT was 2 years (IQR <1,3 years). 
Table 1 shows response rate with demographic metrics.  There were significant differences with age 
(youngest patients having the lowest rate), time on RRT (rate declining as time increased) and SIMD 
quintile (most deprived responding the least).  Response rate was independent of gender, PRD group 
and dialysis location. 
Table 2 shows response rate with census variable.  Response rates were higher from patients with a 
URR over 65%, arteriovenous (AV) access, using the buttonhole technique and those on HDF.  It was 
independent of haemoglobin concentration.  
Linkage with Demographic Data 
PROMs scores were linked with patient demographic data (Table 3).  One-way ANOVAs were 
performed between each variable and the 5 individual components of the KDQOL™-36.  (While 
statistical significance and clinical relevance are not synonymous, all our statistically significant 
results had a mean score difference of at least the 5 points thought to be clinically relevant.) 
There was a significant difference across all five components of the KDQOL™-36 with age.  The 
younger age groups had lower scores across the kidney disease specific components.  Physical and 
mental composite scores were less separated with age.   
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There was also a significant difference with SIMD quintile in the categories symptom/problems of 
kidney disease, burden of kidney disease and physical and mental composite scores (one way 
ANOVA, p<0.05).  Those from SIMD quintiles 1 and 2 (most deprived) generally scored lower than 
those from quintiles 3-5.   
In relation to PRD, a significant difference was demonstrated across the 3 kidney disease specific 
components of the questionnaire and physical composite score.  Patients with diabetic nephropathy 
scored the lowest. 
There was no significant difference between PROMs scores with gender, time spent on RRT, nor 
dialysis provision (main versus satellite unit). 
Ethnicity is poorly recorded on the SRR and was not examined.  The 2011 census reports 96% of the 
Scottish population as Caucasian.11  
Linkage with Clinical Variables 
PROMs scores were linked with census clinical variables (Table 4).  Patients with a URR over 65% had 
higher scores in relation to symptoms of kidney disease, effects of kidney disease, physical and 
mental composites (one way-ANOVA, p<0.05).   
Significant differences were seen in the symptoms/problem list and effects of kidney disease with 
calcium level.  Patients with hypercalcaemia scored lower.  There were no significant differences 
with haemoglobin or phosphate concentrations.   
Patients who used arteriovenous access as opposed to a central venous catheter (CVC) had 
significantly higher scores in the burden of kidney disease (one way-ANOVA, p<0.05), physical and 
mental composite scores (one way-ANOVA, p<0.01).  Those who used the buttonhole technique had 
significantly higher scores across all domains.  There were no differences with HD versus HDF. 
The use of the buttonhole technique was put through interactive and additive general linear models 
alongside age, PRD and SIMD quintile.  There were no significant interactions for either model 
indicating the buttonhole technique is associated with improved PROMs independent of these 
additional variables.  
Transplant Data 
The percentage of patients who submitted PROMs and were listed for transplant are shown in Table 
5.  Respondents under 65 years were less likely to be transplant listed than the national average.  
Respondents 65 years or older were as or more likely to be transplant listed than the national 
average.  
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Discussion 
There is a recognised need for registries to extend their data collection to include patient-reported 
data of experience and outcomes; however this is currently not widely done.  To the best of our 
knowledge, this is the first description of routine collection of PROMs across a national renal 
registry’s haemodialysis population.   
Nationwide collection of PROMs requires organisation and commitment from all units.  Our 
response rate increased from 31% to 48% following interventions to increase staff awareness and 
improve patient information letters.  We anticipate that institution of PROMs into annual census 
data collection would increase this response rate further, however patients’ ability and/or 
inclination to participate will always impact on this.  When questionnaires were completed, 
generally all questions were answered.  The exception was the question regarding the effect of 
kidney disease on sex life (incomplete in 13%).    
In current clinical practice, PROMs have been used for monitoring patients’ progress and in shaping 
local policy and practice.5,12-13  Their use has been associated with lower emergency department 
attendance and increased survival.14  In the renal population most studies have been observational.  
Few have addressed causal relationships and whether targeted interventions can improve PROMs.  
We hope that routine longitudinal collection of PROMs will identify the problems that are important 
to our patients, and ways to improve these.   
Whilst we cannot prove causal relationships between measured parameters and PROMs, we have 
demonstrated associations.  We saw higher PROMs in our more elderly patients (>65 years), as 
previously reported.15  Younger patients on haemodialysis may perceive their illness as more of a 
‘challenge’ or ‘threat’, potentially as the significant lifestyle changes that occur with ERF impact 
more heavily upon their multifarious responsibilities.16  As more young patients will be transplanted 
than their older counterparts, it is worth bearing in mind that those on haemodialysis may not be 
representative of their age group as a whole.  In addition, our respondents under 65 were less likely 
to be on the transplant list than the national average which may accentuate this effect.   
We also demonstrated a significant effect of socioeconomic background on PROMs, with the most 
deprived scoring the lowest.  This is a concern: these patients already have reduced access to 
transplantation and have a higher mortality on the transplant waiting list.17  Those from higher 
socioeconomic classes with transplants also have better graft and patient survival.18  As patients with 
renal transplants experience better HRQOL19,20 and survival21 than those on dialysis, developing 
strategies to reduce these class differences is vital.   
Patients with diabetic nephropathy scored lower than patients with other renal diagnoses.  This 
could be related to the higher morbidity and mortality that these patients suffer from cardiovascular 
disease, alongside other problems such as more frequent loss of vascular access.22 The incidence of 
patients starting RRT for diabetic nephropathy is rising with a corresponding increase in the 
challenge to preserve quality of life for these patients.   
We found no significant effect of haemoglobin or phosphate concentration on PROMs.  Previous 
studies have suggested maintaining haemoglobin within the normal range is associated with fewer 
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physical symptoms.23,24  There is little information on how phosphate control impacts upon PROMs; 
however phosphate binders do create a substantial pill burden which itself has a negative impact on 
HRQOL.25  The patients completing our survey form a predominantly stable cohort with well 
controlled biochemical parameters which may explain why these variables have not had an impact in 
our study. 
Patients who dialysed through AV access also achieved higher scores than those who dialysed 
through a CVC.  This may relate to lower infection rates and increased long term patency with 
fistulae.26,27 
Our study has limitations.  Caution must be used in generalising our findings due to a relatively low 
response rate and over representation from those aged over 65, those more recently started RRT 
and those resident in less deprived areas.  Additionally, we recognise that in some centres dialysis 
staff assisted patients complete their questionnaire, which may lead to reporting bias.  One unit 
used an independent patient officer to assist with completion.   
This is however the first description of routine collection of PROMs in a national haemodialysis 
cohort.  Attaining recommended standards in vascular access and URR is associated with improved 
PROMs, highlighting the importance of efforts to reach these targets.  We were struck by the 
associations of age and SIMD with PROMs.  Government policy is to address health inequalities and 
renal services must institute measures to achieve those aims.28 Measures to actively engage with 
younger and more socio-economically deprived patients to participate in such surveys and to 
identify interventions to improve PROMs are needed.   
Despite the challenges that exist in collecting PROMs, we believe this to be a worthwhile activity.  
Quality of life is as important as survival to many patients so determining key contributors to it and 
optimising these is vital. 29 There is also an association between PROMs and mortality in 
haemodialysis patients, making it a potential prognostic marker.30       
We hope our experience will stimulate discussion and enthusiasm for other registries to collect 
similar data, allowing wider comparisons to be drawn and ultimately leading to improvements in 
care for patients with ERF and other chronic diseases.    
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Tables and Figures 
Demographic Variable Response rate (%) 
(No. linked 
forms/total no. on HD) 
Significance of 
difference (χ2 test)* 
Age (years) 18-44 26 (54/209) 
p=0.01  45-64  40 (277/699)  65-74 45 (228/506) 
 >75 39 (179/458) 
Gender Male 38 (413/1089) n.s.  Female 42 (325/783) 
Time on RRT <1 year 46 (233/508) 
p=0.002 
 >1 year <5 years 38 (380/988) 
 >5 years <10 years 33 (100/300) 
 >10 years 33 (25/76) 
SIMD Quintile 1 (most deprived) 32 (172/531) 
p<0.001 
 2 41 (174/428) 
 3 40 (144/363) 
 4 48 (161/332) 
 5 (least deprived) 40 (87/218) 
PRD Glomerulonephritis 36 (113/317) 
n.s. 
 Interstitial 39 (167/431) 
 Multisystem 44 (175/396) 
 Diabetes 39 (176/450) 
 Unknown/missing 38 (107/278) 
Dialysis Location Parent Unit 39 (367/944) n.s.  Satellite Unit 40 (371/928) 
Table 1.  PROMS questionnaire response rate with demographic variable from 2016 SRR census data.  
n.s., not significant (p>0.05).  * Excluding ‘not recorded’ or ‘not known’; n.s., not significant (p>0.05). 
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Census Variable Response rate (%) 
(No. linked forms/total 
no. on HD 
Significance of 
difference (χ2 test)* 
Haemoglobin (g/L) Not recorded 23 (19/82) 
n.s.  <100 36 (111/309)  100-120 42 (441/1058) 
 >120 39 (167/423) 
Urea reduction ratio Not recorded 30 (33) 
p=0.002  <65% 31 (72) 
 >65% 41 (633) 
Access type Not recorded 14 (10) 
p=0.015  Central venous access 35 (169) 
 AV Access 43 (559) 
Buttonhole technique Not known 17 (25) 
p=0.006 
  Yes 46 (250) 
 No 39 (463) 
Haemodiafiltration Not recorded 36 (162/456) 
P<0.001  Yes 46 (382/828) 
 No 33 (194/588) 
Table 2.  PROMs response rate with clinical census variable from 2016 SRR census data.  * Excluding 
‘not recorded’ or ‘not known’; n.s., not significant (p>0.05). 
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Table 3.  Mean and standard deviation PROMs scores based on census demographic variables, and 
one-way ANOVA. 
  
  
Symptom/ 
Problem 
List 
Effects of 
Kidney 
Disease 
Burden of 
Kidney 
Disease on 
Daily Life 
SF-12 
Physical 
Composite 
SF-12 
Mental 
Composite 
  
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Age 
18-44 (n=54) 61 (21) 49 (24) 27 (24) 31 (10) 41 (12) 
45-64 (n=277) 62 (21) 52 (26) 32 (27) 29 (12) 40 (16) 
65-74 (n=228) 70 (23) 65 (24) 39 (29) 31 (12) 46 (16) 
>75 (n=179) 69 (19) 66 (22) 40 (28) 26 (14) 39 (21) 
One-way ANOVA p=0.001 p=0.001 p=0.001 p=0.001 p=0.001 
Gender 
F (n=325) 67 (21) 59 (25) 36 (28) 29 (12) 41 (17) 
M (n=413) 66 (22) 60 (25) 36 (28) 29 (13) 42 (17) 
One-way ANOVA p=0.472 p=0.848 p=0.932 p=0.528 p=0.476 
Time on 
RRT 
(years) 
<1 (n=233) 67 (19) 58 (24) 34 (25) 29 (13) 41 (17) 
≥1 < 5 (n=380) 65 (23) 58 (26) 35 (29) 30 (13) 42 (17) 
≥ 5 < 10 (n=100) 68 (22) 64 (22) 39 (34) 27 (14) 39 (20) 
≥ 10 (n=25) 66 (24) 66 (26) 44 (34) 32 (9) 49 (15) 
One-way ANOVA p=0.466 p=0.079 p=0.266 p=0.094 p=0.143 
SIMD (1 
most 
deprived- 
5 least 
deprived) 
1 (n=172) 60 (24) 55 (26) 30 (27) 28 (12) 38 (17) 
2 (n=174) 65 (20) 57 (24) 34 (27) 30 (13) 41 (17) 
3 (n=144) 67 (23) 60 (24) 38 (29) 29 (13) 42 (18) 
4 (n=161) 70 (20) 63 (27) 42 (29) 32 (13) 44 (16) 
5 (n=87) 71 (18) 66 (23) 33 (34) 27 (13) 41 (19) 
One-way ANOVA p<0.001 p=0.06 p=0.02 p=0.018 p=0.041 
PRD 
GN (n=113) 64 (23) 59 (25) 34 (27) 28 (12) 42 (17) 
Interstitial (n=167) 67 (21) 61 (26) 39 (29) 33 (13) 43 (15) 
Multisystem (n=175) 68 (21) 62 (25) 38 (29) 29 (13) 43 (18) 
Diabetes (n=176) 62 (23) 52 (25) 28 (24) 26 (12) 39 (18) 
Unknown (n=107) 70 (18) 65 (23) 41 (29) 30 (14) 42 (19) 
One-way ANOVA p=0.03 p<0.001 p<0.001 p<0.001 p=0.152 
 Satellite 
Unit 
No (n=367) 67 (22) 60 (26) 36 (29) 30 (13) 42 (17) 
Yes (n=371) 65 (21) 59 (25) 35 (27) 28 (12) 41 (17) 
One-way ANOVA p=0.122 p=0.357 p=0.546 p=0.128 p=0.228 
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 Symptom/ 
Problem List 
Effects of 
Kidney 
Disease 
Burden of 
Kidney Disease 
on Daily Life 
SF-12 
Physical 
Composite 
SF-12 
Mental 
Composite 
  Mean (SD) Mean (SD) Mean (SD) Mean(SD) Mean (SD) 
Hb (g/dL) Hb<100 (n=111) 66 (22) 60 (25) 33 (26) 27 (14) 39 (18) 
Hb 100-120 (n=441) 67 (21) 61 (25) 37 (28) 30 (12) 42 (17) 
Hb>120 (n=167) 64 (24) 57 (27) 36 (29) 30 (13) 42 (17) 
One-way ANOVA P=0.371 P=0.289 P=0.482 P=0.193 P=0.146 
URR <65% (n=72) 61 (22) 53 (25) 28 (28) 26 (12) 36 (17) 
>65% (n=633) 66 (16) 60 (19) 36 (31) 29 (17) 42 (22) 
One-way ANOVA p=0.031 p=0.031 p=0.22 p=0.015 p=0.002 
Calcium 
(mmol/L) 
<2.2 (n=119) 65 (22) 58 (25) 32 (28) 28 (13) 40 (17) 
2.2-2.6 (n=561) 67 (21) 61 (26) 37 (28) 29 (13) 42 (17) 
>2.6 (n=48) 59 (19) 50 (26) 30 (25) 29 (16) 40 (19) 
One-way ANOVA p=0.048 p=0.011 p=0.060 p=0.554 p=0.397 
Phosphate 
(mmol/L) 
<1 (n=54) 64 (22) 64 (26) 24 (28) 26 (13) 34 (18) 
>1-<2 (n=519) 67 (20) 60 (24) 38 (27) 28 (13) 43 (17) 
>2 (n=149) 64 (18) 55 (32) 36 (24) 29 (14) 42 (10) 
One-way ANOVA p=0.276 p=0.053 p=0.531 p=0.478 p=0.312 
Access 
modality 
AV Access (n=559) 67 (22) 60 (25) 35 (29) 30 (12) 40 (16) 
CVC Access 
(n=169) 64 (21) 57 (24) 29 (25) 24 (13) 32 (19) 
One-way ANOVA p=0.157 p=0.166 p=0.017 p<0.001 p=0.003 
Buttonhole No (n=169) 65 (22) 58 (25) 31 (26) 25 (13) 38 (18) 
Yes (n=250) 69 (21) 63 (25) 25 (30) 25 (12) 33 (16) 
One-way ANOVA p=0.014 p=0.009 p<0.001 p<0.001 p=0.008 
HDF No (n=194) 63 (22) 57(25) 32 (28) 28(12) 39 (18) 
Yes (n=382) 66 (23)  59(25) 35(28) 29(13) 42 (17) 
One-way ANOVA p=0.156 p=0.435 P=0.177 P=0.105 P=0.096 
Table 4.  Mean and median PROMs scores based on census clinical variables, and one-way ANOVA. 
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Age (years) PROMs Responders Transplant Listed (%) 
(Number of patients) 
Scottish Average Transplant Listing (%) 
18-44 46% (25) 74% 
45-64 25% (69) 50% 
65-74 13% (29) 13% 
>75 2% (3) 1% 
Table 5.  Percentage of PROMs responders that are transplant listed compared to Scottish average. 
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